ArticleCancer gene therapy2002

A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.

Teiji Takeda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.